Journal of the American College of Nutrition, Vol. 23, No. 5, 534S-537S (2004)
Published by the American College of Nutrition
Amiloride Increases Neuronal Damage after Traumatic Brain Injury in Rats
Renee J. Turner, BSc,
Corinna Van den Heuvel, PhD and
Robert Vink, PhD
Department of Pathology, University of Adelaide, Adelaide, SA, AUSTRALIA
Address reprint requests to: Robert Vink PhD, Department of Pathology, University of Adelaide, Adelaide, SA, AUSTRALIA. E-mail: robert.vink{at}adelaide.edu.au
 |
ABSTRACT
|
|---|
Objective: It is well known that traumatic brain injury (TBI) decreases brain free magnesium (Mg) concentration, and that administration of Mg salts after TBI restores concentration of Mg in brain and improves functional outcome. In the presence of hemorrhage, administration of Mg salts exacerbates the injury process and worsens outcome. An alternative to administration of Mg salts may be to prevent cellular loss of Mg with use of amiloride, which inhibits the Na+/Mg2+ exchange.
Methods: In the present study, male, adult Sprague-Dawley rats were injured using the impact acceleration model of diffuse TBI and administered either 100 mols/kg i.v. amiloride, or an equal volume of 50% DMSO/saline, 30 minutes (min) after injury.
Results: Amiloride did not improve functional outcome (motor or cognitive outcome) after TBI relative to vehicle treated controls. Histologically, treatment with amiloride significantly increased hippocampal caspase-3 expression (apoptosis), axonal swellings in the medulla and the degree of dark cell change (cell stress) in the cortex. Phosphorus NMR demonstrated that amiloride did not increase free Mg concentration after injury.
Conclusions: Thus, amiloride is ineffective in preventing Mg loss after TBI when administered 30 min after trauma. Moreover, by administering amiloride after the TBI-related Mg decline has already been initiated, it may exacerbate injury by, in part by inhibiting Na+/Mg2+ antiport and preventing entry of Mg back into the cell, and also by inhibiting other Na+ linked transporters.
Key words: apoptosis, brain Mg, traumatic brain injury, hemorrhage, Mg treatment, Amiloride, Na+/Mg2+ antiport
 |
INTRODUCTION
|
|---|
Traumatic brain injury (TBI) is the biggest killer of individuals under 45 years of age and often leaves survivors with life-long motor and cognitive deficits that impair their quality of life. Cell damage that occurs following TBI is caused by both primary and secondary injury mechanisms, the latter being made up of delayed biochemical and physiological factors [1]. This delayed injury therefore provides a window of opportunity for therapeutic intervention. A number of studies have now demonstrated that decline in brain free magnesium (Mg2+) concentration is a critical secondary injury factor after TBI, and that this decline can be treated with the administration of Mg2+ salts with consequent improvement in neuronal cell survival and an associated improvement in functional outcome [2,3]. However, Mg is a vasodilator and its administration in the presence of hemorrhage may increase the hemorrhage and exacerbate the injury. Indeed, in experimental TBI, administration of Mg2+ in the presence of ongoing hemorrhage has been shown to be deleterious to outcome [4]. An alternative to Mg2+ therapy may be to inhibit neuronal Mg2+ loss. A number of mechanisms may account for Mg2+ efflux from a cell, with the Na+/Mg2+ antiporter being the best described to date [5,6]. Therefore, in the present study we have administered the Na+/Mg2+ transport inhibitor, amiloride, to rats after TBI and assessed the effects of the intervention on functional outcome, brain free Mg2+ and neuronal cell death.
 |
MATERIALS AND METHODS
|
|---|
Adult male Sprague-Dawley rats (350450 g) were group housed on a 12 hour (h) night-day cycle and provided with a standard diet of rodent pellets and water ad libitum. Animals were injured using the 2 m impact acceleration model of diffuse TBI described in detail elsewhere [7,8]. Briefly, rats were anesthetised with sodium pentobarbital (60 mg/kg) or halothane and body temperature maintained at 37°C. A midline incision was performed to expose the skull and a stainless steel disc (10 mm diameter x 3 mm thick) was fixed to the skull centrally between the bregma and lambda sutures using polyacrylamide adhesive. Following surgery, animals were placed in the prone position on a 10 cm foam block and the foam block placed beneath the injury device. Injury was induced by release of a 450 g brass weight from a height of 2 m onto the steel disc. Transient apnea was noted in all animals after trauma, and respiration during this time was maintained by mechanical ventilation. At 30 min following trauma, the rats (n = 17/group) were intravenously administered either 100 µmol/kg of amiloride or an equal volume of DMSO/saline vehicle.
Animals (n = 8/group) were allowed to recover and were subsequently assessed for motor and cognitive outcome over the next 7 days using the rotarod and Barnes Maze tasks, respectively. The rotarod consists of a rotating assembly of 18 1 mm rods [9]. Animals were placed on the device and the speed of rotation was increased from 0 rpm to a maximum of 30 rpm, with each speed maintained for 10 s. The time at which the animals completed the 2 min task, fell off completely, or gripped the rungs for 2 consecutive turns without walking was recorded. Cognitive outcome was assessed using the Barnes Maze which consists of a 1.22 m diameter raised circular platform with 18 holes, 9.5 cm in diameter, evenly spaced around the circumference [10,11]. Animals were required to locate the escape tunnel beneath one of the holes in response to aversive sound and light stimuli. The latency of each animal to locate and enter the escape tunnel was recorded. Animals were trained in both tasks for a 5-day period pre-injury.
Further subgroups of animals were used for phosphorus (P) magnetic resonance spectroscopy (n = 6/group) or histology and immunohistochemistry (n = 3/group). For P-spectroscopy, animals were placed centrally within a 7.0 telsa magnetic resonance spectrometer and spectra obtained in 30 min blocks for 4 h using a 9 x 5 mm surface coil placed centrally over the exposed skull as previously described in detail elsewhere [4]. Spectra were analysed for intracellular pH and brain free Mg concentration. For histology and immunohistochemistry, animals were killed 24 h post-TBI and their brains perfusion fixed with 4% paraformaldehyde. Brains were then embedded in paraffin, cut into 5 µm coronal sections and used for hematoxylin and eosin (H&E) staining and caspase-3 immunohistochemistry. Semi-quantitative counts for positive neurones in preselected regions of the cortex and hippocampus were obtained using light microscopy.
All data were analyzed using analysis of variance and Student Newman Keuls post-hoc tests. Significance level was taken as p < 0.05.
 |
RESULTS
|
|---|
Following injury, all animals demonstrated a significant decline in rotarod performance from pre-injury scores (Fig. 1). Consistent with previous results, animals displayed improved performance over time with repeated exposure to the task [8]. No significant differences in mean rotarod scores were observed between the amiloride and vehicle-treated groups at any time over the 7-day assessment period. Similar results were observed in the Barnes maze cognitive tests where all animals demonstrated profound cognitive deficits on day 1 post-TBI, and a gradual improvement in function with repeated exposure to the task (data not shown). Again, no differences were observed between the treatment groups.
Analysis of the H&E stained coronal sections through both the cortex and hippocampus demonstrated a significant increase in dark cell change (DCC), defined as dark, purple stained, contracted, and abnormally shaped neurons, in vehicle treated animals as compared to uninjured shams (Fig. 2). Treatment with amiloride resulted in at least a 2-fold increase in the number of neurons undergoing DCC, suggesting an increase in the level of cell stress after amiloride treatment. These increases in DCC observed in the amiloride group were significant (p < 0.05) when compared to the vehicle treated group. Amiloride-treated brains also showed a significant increase in neuronal caspase-3 immunoreactivity in both the hippocampus and cortex, and at least a two-fold increase (p < 0.05) in the number of axonal swellings in the medulla compared to shams and vehicle treated animals (results not shown).

View larger version (115K):
[in this window]
[in a new window]
|
Fig. 2. Dark cell change in H&E stained sections of hippocampus and cortex in (A) sham animals; (B) vehicle treated animals; and (C) amiloride treated animals.
|
|
P-magnetic resonance spectroscopy demonstrated that there was a significant decline (p < 0.05) in brain free Mg2+ concentration after injury in all animals with values falling from mean pre-injury values of approximately 0.5 mM to less than 0.3 mM in both groups. Treatment with amiloride at 30 min after trauma did not significantly alter the brain free Mg2+ concentration and there was no significant difference between the treatment groups at any time point in the 4 h monitoring period.
 |
DISCUSSION
|
|---|
The current experiment has demonstrated that amiloride did not improve functional outcome when administered 30 min after induction of traumatic brain injury in rats, and exacerbated neuronal injury as determined by H&E staining and caspase-3 immunoreactivity. Amiloride also did not increase post-traumatic concentration of brain free Mg. While confirming that a sustained decline in brain Mg is associated with functional deficits after brain trauma, amilorides inability of to restore Mg concentration was unexpected, given that the compound is a blocker of Na/Mg2+ antiport [5,6].
The interpretation of DCC remains controversial [7]. However, if DCC represents damaged and stressed neurons, then the lack of improvement in motor outcome may be explained by an adverse effect of amiloride on neurones. The concept that amiloride may have an adverse affect on neurones was supported by the increase in caspase-3 immunoreactivity observed in the present studies. Similarly, amiloride therapy at least doubled the number of axonal swellings after TBI, indicating that disruption of axons at the level of the medulla may also have prevented an improvement in neurological outcome in these animals.
Our findings contradict reports that amiloride may be neuroprotective [12]. In these in vitro studies, amiloride was shown to protect primary cerebellar granule cells from glutamate-induced delayed neuronal death, presumably by inhibiting glutamate n-methyl-D-aspartate receptor activity. However, the protection was highly dependent upon the time-point at which the inhibitor was added to the culture medium. When added concurrently with glutamate, amiloride was highly protective. In contrast, when added after glutamate exposure, the neuroprotective effect was markedly reduced. This suggests that there may be a strict time dependence associated with the protective properties of amiloride. When applied to our own in vivo results, it suggests that amiloride was administered too late after TBI to be effective. The fact that brain intracellular free Mg concentration is already low at 30 minutes after injury, and that amiloride failed to improve this low Mg concentration, supports the concept that amiloride was administered too late to block Mg loss through the Na+/Mg2+ exchanger.
Why post-traumatic amiloride administration exacerbated neuronal cell death after TBI is unclear, although there are several possibilities. Amiloride is a non-specific Na+ transport inhibitor and inhibition of other Na+ transporters may have proven detrimental following injury. Block of the Na+/H+ exchange may have prevented H+ efflux from cells, thereby decreasing intracellular pH. This is unlikely since we did not observe acidosis in the magnetic resonance studies. Alternatively, block of the Na+/Ca2+ exchanger may exacerbate injury by preventing Ca2+ efflux from cells, thus markedly increasing intracellular Ca2+ concentration and exacerbating Ca-induced injury. Finally, inhibition of the Na+/Mg2+ exchanger after Mg has already left the cells may prevent later Mg re-entry, thus preventing Mg from participating in intracellular neuronal repair.
 |
CONCLUSIONS
|
|---|
Post-traumatic amiloride administration did not improve neurological outcome following TBI in rats. Moreover, it increased neuronal injury as indicated by the increased dark cell change, axonal swellings and caspase-3 immunoreactivity in both the hippocampus and cortex. We conclude that administration of amiloride at 30 mins after trauma is too late to prevent Mg2+ efflux from cells and may in fact exacerbate injury through prevention of Mg2+ influx at later time points. Further studies investigating the administration of amiloride prior to injury may provide information as to whether Mg2+ efflux through the Na/Mg antiport contributes to the Mg2+ decline after TBI.
 |
ACKNOWLEDGMENTS
|
|---|
We thank Robert Beveridge for his technical assistance with the magnetic resonance experiments.
Received August 5, 2004.
 |
REFERENCES
|
|---|
- McIntosh TK, Saatman KE, Raghupathi R, et al: The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms.Neuropathol Appl Neurobiol24
:251
267,1998
.[Medline]
- Vink R, Cernak I: Regulation of brain intracellular free magnesium following traumatic injury to the central nervous system.Front Biosci5
:656
665,2000
.
- Vink R, Nimmo AJ, Cernak I: An overview of new and novel pharmacotherapies for use in traumatic brain injury.Clin Exp Pharmacol Physiol28
:919
921,2001
.[Medline]
- Heath DL, Vink R: Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration.J Neurotrauma18
:465
469,2001
.[Medline]
- Gunzel D, Schlue WR: Sodium-magnesium antiport in Retzius neurones of the leech Hirudo medicinalis.J Physiol (Lond)
,491
:595
608,1996
.[Medline]
- Gunther T, Vormann J: Mg2+ efflux is accomplished by an amiloride-sensitive Na+/Mg2+ antiport.Biochem Biophys Res Commun130
:540
545,1985
.[Medline]
- Foda MAA, Marmarou A: A new model of diffuse brain injury in rats; Part II: morphological characterization.J Neurosurg80
:301
313,1994
.[Medline]
- OConnor C, Heath DL, Cernak I, Nimmo AJ, Vink R: Effects of daily versus weekly testing and pre-training on the assessment of neurologic impairment following diffuse traumatic brain injury in rats.J Neurotrauma20
:985
993,2003
.[Medline]
- Hamm RJ, Pike BR, ODell DM, Lyeth BG, Jenkins LW: The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury.J Neurotrauma11
:187
196,1994
.[Medline]
- Barnes CA: Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat.J Comp Physiol Psychiat93
:74
104,1979
.
- Fox GB, Fan L, LeVasseur R, Faden AI: Effect of traumatic brain injury on mouse spatial and nonspatial learning in the barnes circular maze.J Neurotrauma15
:1037
1046,1998
.[Medline]
- Andreeva N, Khodorov B, Stelmashook E, Sokolova S, Cragoe E Jr, Victorov I: 5-(N-ethyl-N-isopropyl)amiloride and mild acidosis protect cultured cerebellar granule cells against glutamate-induced delayed neuronal death.Neuroscience49
:175
181,1992
.[Medline]